Status:
COMPLETED
Intestinal Microbiome After Gastrectomy
Lead Sponsor:
Vilnius University
Collaborating Sponsors:
Medical University of Graz
National Cancer Institute (NCI)
Conditions:
Gastric Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The gastric barrier plays a major role in the maintanance of the distal intestinal microbiome composition. It has been shown before that the use of gastric acid suppression medication, such as proton ...
Eligibility Criteria
Inclusion
- age 18 years and above
- history of radical removal of gastric cancer (Test group and Control group 1) or PPI (Control group 3)
- informed consent
Exclusion
- chemotherapy or radiotherapy 12 months prior to inclusion
- gastric stump cancer
- usage of antibiotics, pro- pre or synbiotics, H2-blocker 1 month prior to inclusion
- PPI use (except for Control group 3) 1 month prior to inclusion
- history of radical removal of gastric cancer (Control group 2-3)
- history of gastrointestinal tract resections (other than gastric)
- recurrence of gastric cancer
- current non-gastric malignancies
Key Trial Info
Start Date :
April 1 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2019
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT03418428
Start Date
April 1 2018
End Date
December 1 2019
Last Update
January 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Cancer Institute
Vilnius, Lithuania